- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Cadila Healthcare is now Zydus Lifesciences
New Delhi: The Zydus group announced its new brand identity with the listed entity of the group Cadila Healthcare Ltd. to be known as Zydus Lifesciences Ltd.In the new logo, two hearts come together to enclose 'us' at the core. The heart represents the company's inclusiveness. The Teal and Purple colours represent the pillars of science and care. While the dynamic teal expresses Zydus'...
New Delhi: The Zydus group announced its new brand identity with the listed entity of the group Cadila Healthcare Ltd. to be known as Zydus Lifesciences Ltd.
In the new logo, two hearts come together to enclose 'us' at the core. The heart represents the company's inclusiveness. The Teal and Purple colours represent the pillars of science and care. While the dynamic teal expresses Zydus' dynamism and stands for the company's commitment to science, the purposeful purple stands for dedication to care and nurturance. The 'us' in the new Zydus logo represents all the stakeholders including employees, patients, doctors, investors, bankers, business partners, associates and all those who are an integral part of Zydus' journey.
Read also: Zydus gets USFDA nod for diabetes drug Dapagliflozin
Ruchika Sharma joined Medical Dialogue as an Desk Editor for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751